Siegfried Acceleration Hub

Maximize speed to clinical from the start

Accelerate your path to clinical. The Siegfried Acceleration Hub delivers development and manufacturing for early-phase programs in the US.

Your partner for early-phase development and manufacturing, based in the USA

Siegfried is your comprehensive partner for early-phase drug development and manufacturing, from phase appropriate development of analytical and validation method, to comprehensive expertise in chromatography.

tick_sieg_2

End-to-end life cycle management

Providing services from preclinical through commercial, including scale-up, tech transfer, validation and launch. DMFs throughout the US, Canada, Japan and the EU.

 

tick_sieg_2

HIPO and controlled substances

Offering services for highly potent molecules with an OEL of <0.1 mg/m3. DEA registrations (both international and domestic) from research through manufacturing at all levels of controlled substances from CI-CV.

Accelerate speed to clinical

Your early-phase drug development needs a partner who can move fast. Access rapid speed-to-clinical through phase-appropriate analytical and development services, regulatory expertise, and compliant quality systems—all with the capability to manage highly potent and controlled APIs. The Siegfried Acceleration Hub in the US is designed around what you need in early-phase development and manufacturing.

Grafton site with blue sky
lightbulb_siegfried

More than 25 years of experience

An agile team with extensive experience in accelerating drug development through early phases, backed by Siegfried's 150 years of development expertise.

globe_siegfried

Based in the
United States

Regulatory compliance, transparency, and faster development by eliminating offshore transfer risks. Physical proximity enables real-time collaboration, reducing delays and ensuring efficient, sustainable scale-up.

Blue circle with an arrow

Seamless transfer into Siegfried's network

Seamless transfer into Siegfried's global network, from early-phase to commercial manufacturing. All from a single supplier.

Our technologies and capabilities

Route scouting
Alternate synthesis
Phase-appropriate preclinical process development
Registration campaigns
Process validation campaigns
Analytical chromatography method development and validation
Life-cycle project / product management
Advanced filtration technologies
CMC sections of DMFs
OPEX process optimization

Insights on our capabilities

20230424_Siegfried_Barcelona18855-gigapixel-standard-scale-2_00x-1

Three success factors to accelerate your program to clinical trial

20230424_Siegfried_Barcelona18803_300ppi_RGB_RZ (1)

Ask better, move faster: Questions that will accelerate the speed of your program to clinical

Subscribe now to get more expert insights

 

Acceleration hub landing page image 2

Get in touch

Contact us for more information about the Siegfried Acceleration Hub and its offerings